Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.826

-0.5%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jay silberman who wrote (700)	5/8/1996 9:03:00 AM
From: Peter Caradonna	of 14328

Jay, Thanks for the information. I wonder how they pegged it at $50B. Especially since quick diagnosis somewhat invents a market that doesn't exist. For example, how to measure the home HIV test market when there are no indicators as to how many individuals will buy. If $50B is based on currest diagnosis tests, then the number is on the low side. This analysis supports my gut feel that the market can support many thriving companies before there is profit pressure due to competition. One note if you follow this analysis: $500M kits at $10/per is 50M kits. I think the limiting factor is the ability to produce them. How long do you suppose TRIBY would take to ramp up to 50/m kits per year production? Does anyone know the production growth plan for TRIBY? Everyone ready for an up day? peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next